Abbott (ABT) Tops Q3 EPS by 20c, Beats on Revenue, Raises FY22 Guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $108.33 -0.42%
EPS Growth %: +9.2%
Financial Fact:
Basic Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +9.2%
Financial Fact:
Basic Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q3 EPS of $1.15, $0.20 better than the analyst estimate of $0.95. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $9.63 billion.
GUIDANCE:
Abbott sees FY2022 EPS of $5.17-$5.23, versus the consensus of $5.05.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c
- Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
